SALMASO, ALESSANDRA

SALMASO, ALESSANDRA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Juvenile idiopathic arthritis in adulthood : evaluation of disease activity, damage and quality of life 2011 A. SalmasoVASO, NIKOLETADONATI, CHIARAM. RomanoP. Meroni + Article (author) -
Rituximab in juvenile idiopathic arthritis (JIA)non responsive to anti-TNF : experience of 14 patients treated 2010 A. SalmasoB. TeruzziP. Meroni + Article (author) -
Chronic Recurrent Multifocal Osteomyelitis (CRMO) : four cases treated with Aminobisphosphonate (Pamidronate) 2008 B. TeruzziA. SalmasoF. Fantini + Article (author) -
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab 2008 A. SalmasoA. LuratiB. TeruzziF. Fantini + Article (author) -
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 2008 A. SalmasoB. TeruzziM. BiggioggeroF. Fantini + Article (author) -
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis 2008 A. LuratiR. CimazB. TeruzziA. SalmasoF. Fantini + Article (author) -
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy 2007 G. De MarcoA. LuratiB. TeruzziA. SalmasoE. ValcamonicaF. Fantini + Article (author) -
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients 2005 A. LuratiA. SalmasoE. ValcamonicaG. De MarcoTERUZZI, BARBARA LIAF. Fantini + Article (author) -
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments 2005 G. De MarcoE. ValcamonicaA. LuratiA. SalmasoB. TeruzziF. Fantini + Article (author) -
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study 2005 LURATI, ALFREDOMARIASALMASO, ALESSANDRAF. Fantini + Article (author) -